[
  {
    "ts": null,
    "headline": "Becton Dickinson (BDX) Unveils Wearable Injector Trial and Declares US$1.04 Quarterly Dividend",
    "summary": "Becton Dickinson (BDX) recently announced the initiation of a pharma-sponsored clinical trial featuring their BD Libertas Wearable Injector, alongside an affirmed quarterly dividend and leadership changes. These developments coincided with the company's stock increasing 8% over the past month, aligning with the S&P 500's upward trend. The recent trial highlights BDX's focus on innovation in high-demand biologics, potentially enhancing market confidence. Similarly, the dividend declaration may...",
    "url": "https://finnhub.io/api/news?id=fc1268229e7f1d25bba2815b807f9c08204e17cd6dc672b9a2e5926a5778bc1e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753291506,
      "headline": "Becton Dickinson (BDX) Unveils Wearable Injector Trial and Declares US$1.04 Quarterly Dividend",
      "id": 136062799,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BDX",
      "source": "Yahoo",
      "summary": "Becton Dickinson (BDX) recently announced the initiation of a pharma-sponsored clinical trial featuring their BD Libertas Wearable Injector, alongside an affirmed quarterly dividend and leadership changes. These developments coincided with the company's stock increasing 8% over the past month, aligning with the S&P 500's upward trend. The recent trial highlights BDX's focus on innovation in high-demand biologics, potentially enhancing market confidence. Similarly, the dividend declaration may...",
      "url": "https://finnhub.io/api/news?id=fc1268229e7f1d25bba2815b807f9c08204e17cd6dc672b9a2e5926a5778bc1e"
    }
  },
  {
    "ts": null,
    "headline": "Becton, Dickinson and Company (BDX) Fell in Q2 as Earnings Fell Short of Expectations",
    "summary": "Aristotle Atlantic Partners, LLC, an investment advisor, released its “Core Equity Strategy” second quarter 2025 investor letter. A copy of the letter can be downloaded here. The S&P 500 Index rose 10.94% in the second quarter of 2025, marking a rebound of the U.S. equities market. Aristotle Atlantic’s Core Equity strategy returned 14.43% gross of […]",
    "url": "https://finnhub.io/api/news?id=eedec7596dd45910b56fa3a48a71143243ca04b6077d7d6e01395a41a03d55fb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753276839,
      "headline": "Becton, Dickinson and Company (BDX) Fell in Q2 as Earnings Fell Short of Expectations",
      "id": 136044451,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BDX",
      "source": "Yahoo",
      "summary": "Aristotle Atlantic Partners, LLC, an investment advisor, released its “Core Equity Strategy” second quarter 2025 investor letter. A copy of the letter can be downloaded here. The S&P 500 Index rose 10.94% in the second quarter of 2025, marking a rebound of the U.S. equities market. Aristotle Atlantic’s Core Equity strategy returned 14.43% gross of […]",
      "url": "https://finnhub.io/api/news?id=eedec7596dd45910b56fa3a48a71143243ca04b6077d7d6e01395a41a03d55fb"
    }
  },
  {
    "ts": null,
    "headline": "BD Announces First Pharma-Sponsored Clinical Trial Using BD Libertas™ Wearable Injector Technology for Biologic Drugs",
    "summary": "BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announces the first pharma-sponsored combination product clinical trial using the BD Libertas™ Wearable Injector for subcutaneous delivery of complex biologics.",
    "url": "https://finnhub.io/api/news?id=a56c2d8d3ee8df077b61287d550bfdde8c21298c342d0328e05bf7dcec535ec0",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1753267800,
      "headline": "BD Announces First Pharma-Sponsored Clinical Trial Using BD Libertas™ Wearable Injector Technology for Biologic Drugs",
      "id": 136044452,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BDX",
      "source": "Yahoo",
      "summary": "BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announces the first pharma-sponsored combination product clinical trial using the BD Libertas™ Wearable Injector for subcutaneous delivery of complex biologics.",
      "url": "https://finnhub.io/api/news?id=a56c2d8d3ee8df077b61287d550bfdde8c21298c342d0328e05bf7dcec535ec0"
    }
  }
]